"Health economics" from_date:2012

Evaluating mental health decision units in acute care pathways (DECISION): a quasi-experimental, qualitative and health economic evaluation Text onlyJournals LibraryNHS NIHR - National Institute for Health and Care ResearchSelectEMEGHRHSDRHTAPGfARPHR AdvancedJournalsEfficacy and Mechanism EvaluationGlobal Health ResearchHealth and Social Care Delivery ResearchHealth Technology units in acute care pathways (DECISION): a quasi-experimental, qualitative and health economic evaluationSteve Gillard, Katie Anderson, Geraldine Clarke, Chloe Crowe, Lucy Goldsmith, Heather Jarman, Sonia Johnson, Jo Lomani, David McDaid, Paris Pariza, A-La Park, Jared Smith, Kati Turner & Heather Yoeli.Detailed Author informationFunding: Health and Social Care Delivery Research (HSDR) ProgrammeHealth

Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation * Text only * * Home * Journals * * Other NIHR research * * For authors

Health economic evaluation of a herpes zoster vaccination programme for the elderly in Sweden Health economic evaluation of a herpes zoster vaccination programme for the elderly in Sweden 2 This title can be downloaded from: www.folkhalsomyndigheten.se/publications. Some titles may be ordered as printed. You are welcome to cite our texts, but please remember to state the source. Images has been done in conjunction with an evaluation of whether to introduce varicella vaccination into the national vaccination programme for children since both diseases are caused by the varicella zoster virus. The health economic analysis of herpes zoster vaccination was designed for the evaluation of whether it fulfils the criteria for inclusion in a national vaccination programme. The Swedish

Health economic evaluation of varicella vaccination within the Swedish national vaccination programme for children Health economic evaluation of varicella vaccination within the Swedish national vaccination programme for children 2 This title can be downloaded from: www.folkhalsomyndigheten.se/publications. Some titles may be ordered as printed. You are welcome to cite our texts, but please ..................................................................................................................... 13 Methods .................................................................................................................... 14 Epidemiological model ............................................................................................ 14 Health economic analysis ........................................................................................ 16 Parameters and assumptions

Health Economics in Humanitarian Action: Fulfilling the Promise of Sustainable Development for All CHE Research Summary 19Health Economics in Humanitarian Action: Fulfilling the Promise of Sustainable Development for AllWritten by Wiktoria Tafesse and Sumit Mazumdar.Research Team:Julie Jemutai, Chrispus Mayora, Federica Margini, Rana Hajjeh, Rick Brennan, Awad Mataria, Wiktoria Tafesse, Sumit , there is a lack of health economics research to guide healthcare decision-making in these settings. In the first study we looked at the existing health economics research on refugee health provision in sub-Saharan Africa. This geographical area is home to 35% of the world’s refugee population and hosts a large and rapidly growing number of internally displaced people. However, we found little health economics

Hydrogel rectal spacer SpaceOAR in prostate cancer radiation therapy - Health economic evaluation Hydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapy - NIPH NIPH's website uses cookies. Read more about our use of cookies in our privacy policy.Hopp til innhold Search for: Søk Menu To top level Close * Infectious diseases & Vaccines * Antimicrobial resistance * Infectious subscribed to alerts about: * Hydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapyHealth technology assessmentHydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapy - Health economic evaluation Published 10.02.2021 We were commissioned to perform a health technology assessment of SpaceOAR™ hydrogel for prevention of radiation-induced side effects following treatment

Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis: a rapid health technology assessment- health economic evaluation Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis - NIPH NIPH's website uses cookies. Read more about our use of cookies in our privacy policy.Hopp til innhold Search for: Søk Menu To top level Close . Read more about the privacy policy for fhi.noSubscribe me! You have subscribed to alerts about: * Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosisHealth technology assessmentNatalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis: a rapid health technology assessment- health economic evaluation Published 19.05.2021 The Norwegian

Ofatumumab for the treatment of relapsing remitting multiple sclerosis: a rapid health technology assessment– health economic evaluation Ofatumumab for the treatment of relapsing remitting multiple sclerosis - NIPH NIPH's website uses cookies. Read more about our use of cookies in our privacy policy.Hopp til innhold Search for: Søk Menu To top level Close * Infectious diseases & Vaccines policy for fhi.noSubscribe me! You have subscribed to alerts about: * Ofatumumab for the treatment of relapsing remitting multiple sclerosisHealth technology assessmentOfatumumab for the treatment of relapsing remitting multiple sclerosis: a rapid health technology assessment– health economic evaluation Published 19.05.2021 The Norwegian Institute of Public Health (NIPH) have conducted a rapid health

Budget impact analysis: health economic studies Budget impact analysis: health economic studies - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from . Health and social care 3. Public health 4. Health improvement Guidance Budget impact analysis: health economic studies How to use a budget impact analysis to evaluate your digital health product.From: UK Health Security Agency Published 28 January 2021 Get emails about this page Contents 1. What to use it for 2. Pros 3. Cons 4. How to carry out a budget impact analysis 5. Example: Digital

Strengthening capability in global health economics in Africa: a contribution from CHE CHEResearchSummary13StrengtheningcapabilityinglobalhealtheconomicsinAfrica:acontributionfromCHEWrittenbyHelenWeatherlyandJamesLomas.CHE’sglobalhealtheconomicsprogrammeofresearchisexpanding.IntheAfricancontext,manyoftheactivitiesfallundertheThanziprogramme.ThishasevolvedfrombeingoneprogrammeThanzilaOnse

Cost consequence analysis: health economic studies Cost consequence analysis: health economic studies - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content . Health and social care 3. Public health 4. Health improvement Guidance Cost consequence analysis: health economic studies How to use a cost consequence analysis to evaluate your digital health product.From: UK Health Security Agency Published 22 July 2020 Get emails about this page Contents 1. What to use it for 2. Pros 3. Cons 4. How to carry out a cost consequence analysis 5. Example

Cost benefit analysis: health economic studies Cost benefit analysis: health economic studies - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from . Health and social care 3. Public health 4. Health improvement Guidance Cost benefit analysis: health economic studies How to use a cost benefit analysis to evaluate your digital health product.From: UK Health Security Agency Published 9 November 2020 Get emails about this page Contents 1. What to use it for 2. Pros 3. Cons 4. How to carry out a cost benefit analysis 5. Example: The ETHAN

Health economics: a guide for public health teams Health economics: a guide for public health teams - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from . Health and social care 3. Social care 4. End of life care Guidance Health economics: a guide for public health teams Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.From: Public Health England Published 14 May 2017 Last updated 12 August 2021 — See all updates Get emails about this page

Cost utility analysis: health economic studies Cost utility analysis: health economic studies - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from . Health and social care 3. Public health 4. Health improvement Guidance Cost utility analysis: health economic studies How to use a cost utility analysis to evaluate your digital health product.From: UK Health Security Agency Published 13 October 2020 Get emails about this page Contents 1. What to use it for 2. Pros 3. Cons 4. How to carry out a cost utility analysis 5. Example: The PAS

Cost effectiveness analysis: health economic studies Cost effectiveness analysis: health economic studies - GOV.UK Skip to main content Cookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content . Health and social care 3. Public health 4. Health improvement Guidance Cost effectiveness analysis: health economic studies How to use a cost effectiveness analysis to evaluate your digital health product.From: UK Health Security Agency Published 13 October 2020 Get emails about this page Contents 1. What to use it for 2. Pros 3. Cons 4. How to carry out a cost effectiveness analysis 5

Care of the older person: Frailty as part of the disablement process: calling for health economic interventions Skip to main contentSubscribe Log In Basket Search Latest content Current issue Archive About Write for UsYou are hereHome Archive Volume 25, Issue 2Email alertsArticleTextArticleinfoCitationToolsShareRapid ResponsesArticlemetricsAlertsPDFCommentaryCare of the older personFrailty as part of the disablement process: calling for health economic interventions Rainier Moreno-LacalleCorrespondence to Dr Rainier Moreno-Lacalle, Saint Louis University, Baguio City 2600, Philippines; moreno@slu.edu.phhttp://dx.doi.org/10.1136/ebnurs-2020-103393Statistics from Altmetric.comSee more detailsTweeted by 5On 1 Facebook pages3 readers on MendeleyRequest PermissionsIf you wish to reuse any

Patient-reported outcome measures suitable for quality of life/well-being assessment in multisectoral, multinational and multiperson mental health economic evaluations Patient-reported outcome measures suitable for quality of life/well-being assessment in multisectoral, multinational and multiperson mental health economic evaluations ======================================================================================================================================================================= * Agata Łaszewska * Timea Mariann Helter * Anna Nagel * Nataša Perić * Judit Simon ## Abstract **Question** The aim was to systematically collate and synthesise existing, publicly available patient-reported outcome measure (PROM) information suitable for quality of life (QOL)/well-being measurement in mental health economic evaluations, with specific focus on their applicability in multisectoral

Health-economic evaluation of the outpatient, inpatient, and public health sector in Germany: Insights from the first three COVID-19 waves. The aim of this study is to quantify the effectiveness and cost-effectiveness of the outpatient and inpatient sectors (specifically intensive care units, ICUs) and local health departments in managing the first three waves of the COVID-19 pandemic in Germany

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022

Analysis of the health economics portfolio funded by the National Institutes of Health in response to published guidance. Health services, economics, and outcomes research (referred to as health economics research hereinafter) is one of the interdisciplinary sciences that the National Institutes of Health (NIH) supports in order to pursue its overall mission to improve health. In 2015, NIH guidance was published to clarify the type of health economics research that NIH would continue to fund. This analysis aimed to determine if there were changes in the number of health economics applications received and funded by NIH after the release of the guidance. Health economics applications submitted to NIH both before and after publication of the guidance were identified using a machine learning